[Bronchial asthma and obesity: common mechanisms]
Insights
Obesity and bronchial asthma (BA) share common mechanisms, including inflammation and genetics. Understanding these links can lead to new treatments for both conditions.
Area of Science:
- Pediatrics
- Immunology
- Metabolic Diseases
Context:
- Rising prevalence of bronchial asthma (BA) and obesity in recent decades.
- Mechanisms linking BA and obesity remain incompletely understood.
- Early life factors like diet, gut microbiota, and growth influence both conditions.
Purpose:
- To analyze the association between bronchial asthma and obesity.
- To explore shared underlying mechanisms and distinct phenotypes.
- To identify potential therapeutic targets.
Summary:
- Obesity-associated BA presents with severe symptoms, frequent exacerbations, and poor control, often without cellular inflammation.
- Key mechanisms include comorbidities (GERD, sleep apnea), obesity-related inflammation (cytokines IL-6, TNF-alpha), oxidative stress, and hormonal changes (leptin, adiponectin).
- Common pathways involve genetic predisposition, systemic inflammation, mechanical factors, and comorbidities.
Impact:
- Highlights unique characteristics of obesity-related BA phenotypes.
- Identifies shared etiological factors between BA and obesity.
- Provides a foundation for developing novel, integrated therapeutic strategies for both conditions.
Abstract:
The prevalence of bronchial asthma and obesity has grown in the recent decades. The mechanisms of these pathologies remain unclear despite a number of publications on the relationship between the two diseases. Analysis of the association of BA with obesity should take into account that both diseases develop in young children undergoing effects of breast milk and specific nutrients, intestinal colonization pattern (neonatal and early childhood), body mass at birth and it growth rate, sedentary lifestyle, and adipokine level in early ontogenesis. The available data suggest that the phenotype of BA associated with obesity is characterized by a number of clear-cut peculiarities (more severe clinical manifestations with frequent exacerbaions and impaired control of the disease). Moreover; such patients show no signs of cellular inflammation. There are several distinct mechanisms characterizing obesity-associated BA, viz. co-morbid conditions such as gastroduodenal reflux disease, sleep apnea, obesity-associated systemic inflammation (elevated cytokine (IL-6, TNF-alpha) levels), oxidative stress, production of obesity hormones (leptin. adiponektin, resistin). Thus, BA and obesity have some common potential mechanisms, including genetic factors, systemic inflammation, mechanical factors, and concomitant diseases. Understanding the common mechanisms of these diseases will promote the development of new therapeutic strategies.
Related Concept Videos
Asthma I: Introduction
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-I: Introduction
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation

